Home » Search
Search Results
7,328 results for 'Search IBJ.com'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Conserve water, too
IBJ’s Nov. 2 editorial “Study water needs while there’s time” should have noted the value of conservation in meeting future needs. Available supply should be carefully stewarded and not “promiscuously pumped,” as one water expert recently put it.
Buggs Temple doesn’t stay empty for long
One of the city’s largest caterers, Thomas Caterers of Distinction Inc., has agreed to lease both levels while it pursues a purchase of the two-story building, the owner of the company said.
Company news
Faced with huge debt payments next year, San Francisco-based Genstar Capital is exploring a sale of Indianapolis-based Harlan Laboratories, the world’s second-biggest provider of lab animals. Genstar, which acquired Harlan in a leveraged buyout in 2005, faces long odds on refinancing $280 million in debt that comes due in July 2014. That’s because Harlan has experienced “double-digit revenue contraction” after sales reached $326 million in 2012, according to a report by Standard & Poor’s. Harlan has been losing ground in its contract research work, analysts say, because pharmaceutical companies have scaled back early-stage research. Harlan employs about 330 people in the Indianapolis area.
The state of Indiana will extend its high-risk insurance pool through the end of January to accommodate Hoosiers who have been unable to enroll in coverage through the federal marketplace, according to TheStatehouseFile.com. The Indiana Comprehensive Health Insurance Association–often called ICHIA–provides coverage for roughly 6,800 individuals with significant medical needs and costs the state about $6.3 million per month. The program was scheduled to shut down at the end of the year. The state created its high-risk insurance pool in 1982 to provide health care options for seriously ill Hoosiers who did not have access to coverage in the private market. Its users tend to have problems including cancer, hemophilia, HIV/AIDS or organ failure. Last spring, the General Assembly passed a law dissolving the program because the patients would become eligible to purchase coverage through the federal marketplace. But state officials now worry those patients won’t be able to sign up in time.
In an attempt to improve public health planning and efforts, researchers at IUPUI have received a $200,000 grant to study whether they can use electronic medical records to measure health outcomes by neighborhood or census block. The two-year study will try to establish a valid method for integrating data from the medical records with other community health indicators such as parks, health care facilities and grocery stores selling fresh produce. “When there is a limited budget for, say, preventing diabetes, the county health department has to determine how to spend its resources,” said Brian Dixon, an informatics professor and researcher at Indianapolis-based Regenstrief Institute Inc., who is leading the study. “One choice is to evenly divide the money across all communities within the county, some of which probably don’t have as much need as others. A second choice is to identify specific areas within the county that might need intervention the most.” The grant was awarded by the National Network of Public Health Institutes with support from the Robert Wood Johnson Foundation.
The bill for Hoosiers’ excess health care spending: About $5 billion per year
Hoosiers’ poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
LIBMAN: Great Recession isn’t over for the arts
As we all know, the Great Recession that began in 2008 was the worst economic disaster to hit America and the global economy since the Great Depression. While the Great Recession is technically over as measured by economists, millions of Americans are still out of work or have stopped searching for work, and some sectors of the economy have not recovered.
ALTOM: Google makes its analytics tracker less useful
Search giant takes away something business owners have come to rely on.
LOU’S VIEW: A pair of trios with DK and the Phoenix
Three choreographers make magic while three couples mine marital misery.
The frightening future that’s haunting hospitals
Why are Indiana’s hospitals cutting jobs. Because they’re spooked about cuts to Medicare payments. They should be.
Indiana’s long fight for less government has politicians protecting own
Economists and politicians on both sides of the aisle have argued for years that streamlining government in Indiana could save millions of dollars, but vested interests and fear of change have stymied real reform.
COLLINS: A Ted Cruz on every corner in Texas
Have you noticed how many lawmakers from Texas were doing crazy things during the government shutdown debacle?
BLOW: Billionaires and welfare lines lengthening
The stock market is hitting record highs. Bank profits are their highest in years. The market for luxury goods is rebounding.
KETZENBERGER: Thoughtful notions from the Vlogbrothers
John and Hank Green, also known as the Vlogbrothers, exchange videos with each other twice a week. Sometimes the videos are funny and sometimes they’re serious, but they’re usually thought-provoking.
MASSON: Juries carry out noble, weighty duty
We ask juries to do a lot in Indiana. In simple terms, juries are a body empaneled to be fact finders as part of the judicial process for resolving criminal charges or civil disputes.
PELATH: Push the marriage amendment at the economy’s peril
For those who can still bear to look, Indiana’s unemployment rate remains stuck above 8 percent.
SHELLA: Youth vote might negate marriage polls
Twenty-fourteen will be a year of love and politics in Indiana.
Company news
Franciscan Alliance blamed lower patient volumes, reimbursement reductions and Obamacare for its decision to eliminate 925 full-time positions through a mix of layoffs, reduced hours, retirements and attrition. The Mishawaka-based Catholic organization, which operates three hospitals in the Indianapolis area, said it is trying to cut expenses by as much as $500 million, or 20 percent, over the next few years. Most other hospitals around Indiana are doing the same. To reach that goal, Franciscan will also cut benefits for its remaining 19,000 employees. Of the 925 positions cut, 275 will come through layoffs. In the Indianapolis area, 83 employees were laid off and another 65 positions are being eliminated. In 2012, Franciscan’s 13 hospitals in Indiana and Illinois pulled in revenue of $2.5 billion, generating a net gain of $110 million, excluding a special accounting charge. However, the hospital chain’s operating profit margin decreased to 4.5 percent from 5.2 percent the previous year.
The National Institutes of Health awarded a $30 million grant to the Indiana Clinical and Translational Sciences Institute, a partnership of Indiana University, Purdue University and the University of Notre Dame. The money will help fund the institute at least through 2018. The Indiana University School of Medicine established the institute in 2008 with a $25 million NIH grant, plus about $25 million in matching grants from IU, Purdue, the state of Indiana and private partners such as Eli Lilly and Co. The institute estimates it supports more than 80 full-time-equivalent professional jobs across Indiana, who work on research in Alzheimer's disease, Parkinson's disease, autism, traumatic brain injury, polycystic kidney disease, and osteoporosis and osteoarthritis.
WellPoint Inc.’s stock fell nearly 5 percent in the second half of last week even though the health insurer reported better-than-expected third-quarter earnings. Investors backed away from health insurers as problems with the new Obamacare exchanges persisted. Indianapolis-based WellPoint earned $656.2 million in the quarter ended Sept. 30, down from $691.2 million in the same quarter a year ago. But because WellPoint has spent $1.2 billion buying back its own stock over the past year, the company’s profit per share actually increased to $2.16 in the latest quarter, from $2.15 a year ago. Excluding investment gains and one-time gains and charges, WellPoint would have earned $2.10 in the third quarter this year. On that basis, analysts were expecting profit of just $1.82 per share, according to a survey by Thomson Reuters. WellPoint raised its full-year profit forecast to $8.40 per share, an increase of 40 cents.
Profit at Eli Lilly and Co. fell 9 percent in the third quarter but still easily beat the expectations of Wall Street analysts. The Indianapolis-based drugmaker earned $1.2 billion in the three months ended Sept. 30, down from $1.3 billion in the same quarter last year. But results from last year were boosted by a payment from former Lilly partner Amylin Pharmaceuticals Inc. Excluding that payment and other special charges, Lilly’s profit-per-share soared 41 percent, to $1.11, up from 79 cents per share a year ago. Analysts had been expecting profit $1.04 per share, according to a survey by Thomson Reuters. This was the last full quarter in which Lilly will maintain its U.S. patents on Cymbalta, its bestselling drug. Sales of the antidepressant grew 11 percent in the quarter to nearly $1.4 billion.
Strong sales of new crop protection products helped Dow AgroSciences LLC cultivate revenue of $1.4 billion in its third quarter, up 8 percent from the same quarter a year ago. But profit for Dow AgroSciences tumbled more than 71 percent—from $63 million in the previous third quarter to $18 million in this year’s quarter. The figure represents earnings before accounting for interest, taxes, depreciation and amortization. Dow attributed the decrease in profit to higher seed returns in North America driven by a late, wet planting season, as well as increased spending on growth investments. Revenue from Dow’s crop protection products rose 10 percent in the quarter, driven by higher sales of herbicides in North America and insecticides in Latin America. Dow AgroSciences is an Indianapolis-based subsidiary of Michigan-based Dow Chemical Co.
Warsaw-based Zimmer Holdings Inc.’s third-quarter profit fell 13 percent to $154.4 million, or 90 cents a share, down from $178.1 million, or $1.02 a share, in the same quarter a year ago. Excluding special charges for restructuring and litigation, Zimmer would have earned $1.25 per share, a penny higher than analysts were expecting. Zimmer’s revenue in the quarter rose 4.8 percent to $1.07 billion. For the year, the company now expects per-share earnings of $5.70, which is near the low end of its previous profit forecast. Its sales continue to be dampened as high unemployment and an uncertain economy in the United States have caused patients to put off hip and knee replacement surgeries.
Bribery scandals sap Lilly’s China growth
Eli Lilly and Co. has been counting on torrid growth in China to help offset losses from patent expirations in other markets, but now slower growth in the Chinese economy and bribery allegations against Lilly and two other drugmakers have hampered Lilly’s growth there.
BlackBerry woes hamper sales for BrightPoint, analysts say
Revenue at the Indianapolis-based provider of mobile-device logistics and distribution fell some $250 million short of expectations in the third quarter, as major customer BlackBerry saw even bigger sales declines.
Ritzier hotels may lure top events, but year-round demand unclear
Indianapolis lacks a five-star hotel, a fact some hospitality experts think could hurt the city’s chances of landing the 2018 Super Bowl. But there’s no consensus on whether the city should go more upscale.